Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

EyePoint, Inc. (EYPT) Balance Sheet

As of 2026-06-30 (10-Q), EyePoint, Inc. (EYPT) reported total assets of $228.2M, total liabilities of $61.8M and shareholders' equity of $166.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $110.5M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EYPTEyePoint, Inc.Follow EYPT — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
34.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2012
Jun 12
FY2013
Jun 13
FY2014
Jun 14
FY2015
Jun 15
FY2016
Jun 16
FY2017
Jun 17
FY2018
Jun 18
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents4.66.915.319.115.316.938.845.322.244.9178.695.6281.399.7101.8110.5
Short-term investments9.93.42.99.413.70.00.00.00.00.033.048.949.8271.2204.370.0
Receivables1.00.60.50.60.50.30.40.611.49.518.415.50.80.60.70.1
Inventory—————0.00.00.32.15.33.62.93.92.31.81.9
Current assets16.012.519.329.830.017.739.947.641.763.1237.7172.8344.8383.3328.7188.8
Total assets20.616.222.732.431.618.771.778.273.091.7263.4180.4355.2418.5364.0228.2
Current liabilities3.23.32.13.35.15.321.721.511.514.923.734.563.349.037.041.9
Long-term debt—————0.017.317.647.238.036.629.3————
Short-term debt——————————0.010.50.0———
Total liabilities7.08.57.79.010.75.360.040.564.673.279.084.088.982.057.961.8
Shareholders' equity13.67.714.923.420.913.311.737.68.318.5184.496.4266.3336.5306.1166.4

USD millions · SEC XBRL

EyePoint, Inc. — questions

How much cash does EyePoint, Inc. have?
$110.5M in cash and cash equivalents as of 2026-06-30.
What are EyePoint, Inc.'s total assets?
$228.2M as of 2026-06-30.
What is EyePoint, Inc.'s shareholders' equity?
$166.4M as of 2026-06-30.

Every figure on this page comes from EyePoint, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.